GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambee Pharmaceuticals Plc (DHA:AMBEEPHA) » Definitions » Debt-to-Revenue

Ambee Pharmaceuticals (DHA:AMBEEPHA) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2004. Start your Free Trial

What is Ambee Pharmaceuticals Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Ambee Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Ambee Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Ambee Pharmaceuticals's annualized Revenue for the quarter that ended in . 20 was BDT0.00 Mil.


Ambee Pharmaceuticals Debt-to-Revenue Historical Data

The historical data trend for Ambee Pharmaceuticals's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambee Pharmaceuticals Debt-to-Revenue Chart

Ambee Pharmaceuticals Annual Data
Trend
Debt-to-Revenue

Ambee Pharmaceuticals Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Ambee Pharmaceuticals's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ambee Pharmaceuticals's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambee Pharmaceuticals's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambee Pharmaceuticals's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ambee Pharmaceuticals's Debt-to-Revenue falls into.


;
;

Ambee Pharmaceuticals Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Ambee Pharmaceuticals's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Ambee Pharmaceuticals's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Ambee Pharmaceuticals Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ambee Pharmaceuticals's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambee Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.

Ambee Pharmaceuticals Headlines

No Headlines